CLPT — ClearPoint Neuro, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1285550 ·
Last close
$10.49
Market Cap
$319.99M
52W High
$30.10
52W Low
$8.27
ADV30
702,087
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 10,880,000 | 6,710,000 | -10,244,000 | -11,337,000 | 86,741,000 | 29,363,000 | 75,965,000 |
| Mar 2026 | 12,128,000 | 7,756,000 | -8,478,000 | -9,552,000 | 93,416,000 | 35,593,000 | 74,575,000 |
| Dec 2025 | 10,410,000 | 6,404,000 | -7,045,000 | -7,786,000 | 97,747,000 | 45,923,000 | 69,727,000 |
| Sep 2025 | 8,861,000 | 5,600,000 | -5,276,000 | -5,891,000 | 60,357,000 | 38,221,000 | 44,483,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,183,000
Investing CF
$30,000
Financing CF
$18,720,000
CapEx
$-1,107,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.12
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-237,799,000
Inventory
$8,813,000
Receivables
$8,395,000
ST Investments
—
EBIT TTM
$-29,330,000
Pretax Income TTM
$-34,584,000
Interest Exp TTM
$5,254,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$42,279,000
EBITDA
$-28,211,000
Free Cash Flow
$-14,050,125
Enterprise Value
$453,100,992
Total Cash
$29,363,000
Total Debt
$63,946,000
Shares Out
30,504,227
Trailing EPS
$-1.18
Book Value
$0.35
ROE
-226.5%
ROA
-24.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 36,971,000 | -24,164,000 | -25,540,000 | 97,747,000 | 69,727,000 | 28,020,000 | -23,925,000 |
| Dec 2024 | 31,390,000 | -19,734,000 | -18,914,000 | 39,189,000 | 13,800,000 | 25,389,000 | -8,950,000 |
| Dec 2023 | 23,955,000 | -22,446,000 | -22,089,000 | 42,661,000 | 21,488,000 | 21,173,000 | -13,720,000 |
| Dec 2022 | 20,551,000 | -16,332,000 | -16,435,000 | 55,490,000 | 18,603,000 | 36,887,000 | -16,167,000 |
TTM Snapshot
Revenues TTM
$40,614,000
NetIncome TTM
$-29,066,000
OpCashFlow TTM
—
Assets (Latest)
$93,416,000
Forward EPS
$-1.20
Max Pain — expiry 2026-10-16
max pain strike: $12.50 · spot: $10.48 · call oi: 7,193 · put oi: 840
Expected Move to 2026-10-16:
±$1.06
(10.16%) —
implied range
$9.41 –
$11.54
· ATM straddle on $10.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SMTI | Sanara MedTech Inc. | $322.04M | $35.05 | — |
| EMBC | Embecta Corp. | $325.79M | $5.75 | — |
| CV | CapsoVision, Inc | $331.31M | $6.62 | — |
| AVHHL | AVITA Medical, Inc. | $303.08M | $1.96 | — |
| OBIO | Orchestra BioMed Holdings, Inc. | $344.40M | $5.73 | — |
News headlines (Yahoo Finance, 1h cache)
ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
2026-09-29 13:30 · Yahoo
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment
2026-09-04 12:14 · Yahoo
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript
2026-08-11 01:48 · Yahoo
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
2026-08-03 22:45 · Yahoo
ClearPoint Neuro Q2 Earnings Call Highlights
2026-08-03 22:03 · Yahoo
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel
2026-07-31 20:05 · Yahoo
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
2026-07-21 20:05 · Yahoo
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
2026-06-18 10:36 · Yahoo
ClearPoint Neuro Shares Jump as FDA Progress for UniQure Therapy Highlights Platform Value
2026-06-17 12:56 · Yahoo
ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
2026-05-27 20:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.